Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-09
2010-11-09
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S333000, C546S334000
Reexamination Certificate
active
07829587
ABSTRACT:
Substituted 2-aminotetralin derivatives as selective alpha 2B agonists can be incorporated in a pharmaceutical composition and can be used in methods of treating an alpha 2B receptor mediated diseases or conditions. The compounds are represented by Formula 1:whereinR1=H, methyl, ethyl, propyl, or cyclobutyl;R2=methyl or H;R3=pyridinylX=C or O.
REFERENCES:
patent: 6953813 (2005-10-01), Bongrani et al.
patent: 0041488 (1981-12-01), None
patent: WO 91/00727 (1991-01-01), None
patent: WO 92/00073 (1992-01-01), None
patent: WO 01/08667 (2001-02-01), None
Kahnt et al, Acta Endocrinologica (1972), 70(2) pp. 315-330.
Robert R. Ruffolo, Jr., Alpha-Adrenoreceptors: Molecular Biology, Biochemistry and Pharmacology, (Progress in Basic and Clinical Pharmacology series, Karger, 1991).
Holtz et al. , “α-Adrenergic Agents. 3. Behavioral Effects of 2-Aminotetralins” Psychopharmacology 77:259-267 (1982).
DeMarinis et al. , “α-Adrenergic Agents. 1. Direct-Acting α1Agonists Related to Methoxamine1”, J. Med. Chem., 24, 1432-1437, 1981.
DeMarinis et al., “α-Adrenergic Agents. 2. Synthesis and α1-Agonist Activity of 2-Aminotetraline1,2” J. Med. Chem. 1982, 25, 136-141.
Ardvidsson et al., “8-Hydroxy-2-(alkylamino)tetralins and Related Compounds as Central 5-Hydroxytryptamine Receptor Agonists”, J. Med. Chem., 27, 45-51,1983.
“Prodrugs and Drug Delivery Systems,” which is a chapter in Richard B. Silverman,Organic Chemistry of Drug Design and Drug Action, 2d Ed., Elsevier Academic Press: Amsterdam, 2004, pp. 496-557.
Princen et al., “Evaluation of SDF-1/CXCR4-Induced Ca2+Signaling by Fluorometric Imaging Plate Reader (FLIPR) and Flow Cytometry”, Cytometry Part A. 51A, pp. 35-45, 2003.
Arvidsson, Lars-Erik; et al.: 8-Hydroxy-2-(alkylamino)Tetralins and Related Compounds as Central 5-Hydroxytryptamine Receptor Agonists, Journal of Medicinal Chemistry, American Chemical Society, vol. 27, No. 1, Jan. 1, 1984, pp. 45-51.
Cossery, J.M.; et al.: Isosteres Oxygenes D'Hydroxy-DI-N-Propylaminotetralines Synthesis De Monomethoxy Et Monhydroxy-(DI-N-Propylamino)-3 Chromannes UN-Propyl-3H ¾ Racemiques: Nouveaux Radioligands Des Sites De Liasonserotoninergiques 5-HT1A Et Dopaminergiques D2. Ooxigen Isosteres of Hydroxy-DI-N-Propylaminotetrali, Journal of Labelled Compounds and Radiopharmaceuticals, John Wiley, vol. 25, No. 8, Jan. 1, 1988, pp. 833-854.
Holz, W.C.; et al.: α-Adrenergic Agents. 3. Behavioral Effects of 2-Aminotetralins, Psychopharmacology, Springer Verlag, vol. 77, No. 3, Jan. 1, 1982, pp. 259-267.
Horn, Alan S.; et al.: Synthesis and Dopaminergic Activity of a New Oxygen Isostere of the 2-Aminotetralins: N, N-Dipropyl-8-Hydroxy-3-Chromanamine, Eur. J. Med. Chem. vol. 23, 1988, pp. 325-328.
Timmermans, Pieter; et al.: Alpha1alpha2-Adrenoceptor Agonist Selectivity of Mono- and Dihydroxy-2-N, N-DI-n-propylaminotetralins, European Journal of Pharmacology, vol. 97, No. 1-2, Jan. 13, 1984, pp. 55-65.
Cappiello John R.
Chow Ken
Garst Michael E.
Gil Daniel W.
Gomez Dario G.
Allergan Inc.
Davis Zinna N
Ene Doina G.
Forrestal Kevin J.
Wurst John E.
LandOfFree
Substituted 2-aminotetralin derivatives as selective alpha... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-aminotetralin derivatives as selective alpha..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-aminotetralin derivatives as selective alpha... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4242517